New ink makes tattoos less permanent

Dec 30, 2006

Scientists at two U.S. universities developed a solution to make tattoos less permanent -- an ink that can be removed with a single laser treatment.

Tattoo removal traditionally is painful, expensive and time-consuming, often involving several laser treatments that aren't always effective and can scar, the New York Post said Friday. An average removal session costs as much as $400.

The new development by scientists at Harvard Medical School and Duke University is to hit the market within a few months. Tattoo artists told the Post they would welcome the new ink as long as it is safe.

Some, though, said they wonder whether the ink, developed by using beads called polymer microspheres, would hold up as well as traditional inks that include heavy metals to help forestall fading.

"It might open the door for some people who are worried about the permanence but, at the same time, the permanence is kind of the point of tattooing," Mehai Bakaty, co-owner of Fineline Tattoo in New York, told the newspaper.

One-in-four U.S. adults has at least one tattoo, the Journal of the American Academy of Dermatology said.

Copyright 2006 by United Press International

Explore further: New drug sales help boost Novartis Q1 profit (Update)

add to favorites email to friend print save as pdf

Related Stories

English prof explores the social life of ink

Oct 30, 2007

Imagine hundreds of people lined up at a department store in New York City, along with 50 police officers to prevent them from crashing the doors. What might cause such excitement? The new iPhone? An appearance by J.K. Rowling? ...

HP Expands into Digital Consumer Electronics

Aug 29, 2004

HP offers consumers keys to living digitally -- simple, personalized experiences HP announced its expansion into multiple new consumer digital entertainment and digital photography categories with a range of o ...

Recommended for you

Amgen misses 1Q views as higher costs cut profit

Apr 22, 2014

Despite higher sales, biotech drugmaker Amgen's first-quarter profit fell 25 percent as production and research costs rose sharply, while the year-ago quarter enjoyed a tax benefit. The company badly missed ...

Valeant, Ackman make $45.6B Allergan bid

Apr 22, 2014

Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion.

User comments : 0

More news stories

Genetic code of the deadly tsetse fly unraveled

Mining the genome of the disease-transmitting tsetse fly, researchers have revealed the genetic adaptions that allow it to have such unique biology and transmit disease to both humans and animals.

Ocean microbes display remarkable genetic diversity

The smallest, most abundant marine microbe, Prochlorococcus, is a photosynthetic bacteria species essential to the marine ecosystem. An estimated billion billion billion of the single-cell creatures live i ...